Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areas
Authors:
- David RyanDRDavid Ryan
- Sally RobinsonSRSally Robinson
- Richard CallanderRCRichard Callander
- Katie StampKSKatie Stamp
- Ruth A. RobertsRRRuth A. Roberts
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 65 (3) , 334-343
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Testicular Development in Cynomolgus MonkeysToxicologic Pathology, 2012
- Safety evaluation to support first-in-man investigations II: Toxicology studiesRegulatory Toxicology and Pharmacology, 2008
- The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidatesNature Reviews Drug Discovery, 2007
- Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth PlateToxicologic Pathology, 2006
- First dose of potential new medicines to humans: how animals helpNature Reviews Drug Discovery, 2004
- THE CHALLENGE OF JUVENILE JUSTICE: ADVOCATING FOR TROUBLED CHILDREN IN TROUBLEIssues in Mental Health Nursing, 2001
- Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticalsHuman & Experimental Toxicology, 2000
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997
- Target organ toxicityToxicology Letters, 1981